Erythropoietin, also known as human erythropoietin, typically needs to be administered twice a week. Human erythropoietin is a kind of drug for the treatment of anemia. The use of human erythropoietin is clinically common as twice a week, and it needs to be used according to the severity of the condition, at the discretion of the physician’s guidance. Erythropoietin is produced by the kidneys, when there are kidney diseases, such as acute glomerulonephritis, renal failure, nephrotic syndrome, etc., may lead to a decrease in the secretion of erythropoietin, which can lead to anemia. Human erythropoietin can be used to treat aplastic anemia and renal anemia. Topical supplementation of erythropoietin can be effective in helping to raise the level of red blood cells in the blood and improve the symptoms of anemia such as hypoxia and cyanosis. Adverse reactions include rash, diarrhea, etc. Contraindications are patients with severe hepatic impairment and patients who are allergic to the product. Human erythropoietin must be used under the supervision of a physician, not self-medication.